1 / 12

Acne Drugs Market Research and Forecast Report 2023-2028

According to the latest research report by IMARC Group, The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/acne-drugs-market

Download Presentation

Acne Drugs Market Research and Forecast Report 2023-2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Acne Drugs Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

  2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Description and Highlights Report Description Global Acne Drugs Market Research Report: The latest report by IMARC, titled “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” the global acne drugs market reached a value of US$ 6.5 Billion in 2022. Acne is a dermatological condition that occurs when the hair follicles in the skin get clogged by sebum, dead skin cells and harmful bacteria. Although it is most common among teenagers, it can affect people of all ages. Factors like emotional stress, hot and humid climate and hormonal fluctuations during puberty can cause the onset of acne by enlarging oil glands under the skin. Acne drugs are used for treating bacterial infections or reduce oil production in the skin, which helps lower the occurrence of acne. These drugs include lifestyle remedies, topical and oral medicines, and medical procedures. Request Free Sample Report: https://www.imarcgroup.com/acne-drugs-market/requestsample

  4. Report Description and Highlights Report Description Global Acne Drugs Market Trends: Acne is one of the most prevalent skin diseases globally and is estimated to affect 9.4% of the population worldwide. Along with this, the increasing prevalence of skin-related diseases due to genetic factors or heavy cosmetics has led to a significant rise in the demand for acne drugs across the globe. Moreover, dermatologists and researchers are developing safer and more advanced treatment drugs with a better understanding of acne pathology. For instance, Paratek and Allergen developed Sarecycline, an oral tetracycline-class drug, for which a tablet formulation is approved in the USA for the treatment of inflammatory lesions of non-modular moderate to severe acne vulgaris. Some of the other medications prescribed by dermatologists include topical retinoids, topical antibiotics, azelaic acid and antibiotic tablets, which are commonly used to treat moderate to severe acne. Looking forward, the market is expected to grow at a CAGR of 5.3% during the forecast period (2023-2028) Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

  5. Report Description and Highlights Report Description Market Summary: Breakup by Acne Type: • Comedonal • Inflammatory • Cystic • Postsurgical/Wound Breakup by Drug Class: • Retinoids • Antibiotics • Hormonal Agents • Combination Drugs • Others Breakup by Drug Type: • OTC Drugs • Prescription Drugs Breakup by Route of Administration:

  6. Report Description and Highlights Report Description • Topical • Oral • Injectable Breakup by Region: • North America • United States • Canada • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom

  7. Report Description and Highlights Report Description • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

  8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • Allergan Plc Bausch Health Companies Inc. Bayer Aktiengesellschaft Cipher Pharmaceuticals Inc. Galderma Holding SA Johnson & Johnson Pfizer Inc. Reckitt Benckiser Group Plc Skinvisible Pharmaceuticals Inc. Sun Pharmaceutical Industries Limited Teva Pharmaceutical Industries Ltd. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/acne-drugs-market

  9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com

More Related